LIM
CRL icon

Lathrop Investment Management’s Charles River Laboratories CRL Stock Holding History

Lathrop Investment Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-26,288
Closed -$3.96M – 86
2025
Q1 		$3.96M Sell
26,288
-1,248
-5% -$209K 0.79% 38
2024
Q4 		$5.08M Buy
27,536
+2,122
+8% +$409K 0.97% 35
2024
Q3 		$5.01M Sell
25,414
-4,874
-16% -$1.01M 0.93% 37
2024
Q2 		$6.26M Buy
30,288
+14,638
+94% +$3.32M 1.22% 34
2024
Q1 		$4.24M Buy
+15,650
New +$3.74M 0.82% 38

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Lathrop Investment Management's CRL Position: Q2 2025 in Review

Lathrop Investment Management sold out of Charles River Laboratories (CRL) in Q2 2025, closing a stake of 26,288 shares — an estimated $3.96M sold.

Lathrop Investment Management first reported a position in CRL in Q1 2024 and held it in 5 quarters. The position peaked at $6.26M in Q2 2024. 519 funds tracked by Wall St. Rank hold CRL as of Q2 2025.

  • Lathrop Investment Management reported no remaining Charles River Laboratories position as of Q2 2025 after selling out during the quarter.
  • Lathrop Investment Management sold 26,288 Charles River Laboratories shares in Q2 2025, an estimated $3.96M.
  • Lathrop Investment Management first reported a position in Charles River Laboratories in Q1 2024 and held it in 5 quarters.
  • Lathrop Investment Management's Charles River Laboratories position peaked at $6.26M in Q2 2024.
  • 519 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2025.

Based on Lathrop Investment Management's 13F filing for Q2 2025, filed 4 Aug 2025.